Los Angeles Capital Management’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-26,544
| Closed | -$596K | – | 1202 |
|
|
2024
Q3 | $596K | Sell |
26,544
-6,701
| -20% | -$151K | ﹤0.01% | 812 |
|
|
2024
Q2 | $694K | Sell |
33,245
-69,076
| -68% | -$1.44M | ﹤0.01% | 766 |
|
|
2024
Q1 | $1.5M | Sell |
102,321
-23,680
| -19% | -$348K | 0.01% | 565 |
|
|
2023
Q4 | $1.3M | Buy |
126,001
+162
| +0.1% | +$1.67K | ﹤0.01% | 590 |
|
|
2023
Q3 | $989K | Buy |
125,839
+16,989
| +16% | +$134K | ﹤0.01% | 645 |
|
|
2023
Q2 | $1.09M | Buy |
108,850
+5,071
| +5% | +$50.7K | ﹤0.01% | 634 |
|
|
2023
Q1 | $922K | Sell |
103,779
-2,700
| -3% | -$24K | ﹤0.01% | 696 |
|
|
2022
Q4 | $1.17M | Buy |
106,479
+38,824
| +57% | +$426K | 0.01% | 658 |
|
|
2022
Q3 | $882K | Buy |
67,655
+54,390
| +410% | +$709K | ﹤0.01% | 746 |
|
|
2022
Q2 | $168K | Buy |
13,265
+260
| +2% | +$3.29K | ﹤0.01% | 1276 |
|
|
2022
Q1 | $182K | Hold |
13,005
| – | – | ﹤0.01% | 1366 |
|
|
2021
Q4 | $376K | Buy |
+13,005
| New | +$376K | ﹤0.01% | 1144 |
|